




Instance: composition-en-63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: CompositionUvEpi
Title: "Composition for fampridine Package Leaflet"
Description:  "Composition for fampridine Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp39498dc221c8f1bc0b8c1dfe4bd3662c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - fampridine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol>
<li>What Fampridine Accord is and what it is used for  </li>
<li>What you need to know before you take Fampridine Accord  </li>
<li>How to take Fampridine Accord </li>
<li>Possible side effects </li>
<li>How to store Fampridine Accord </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What fampridine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What fampridine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fampridine Accord is a medicine used to improve walking in adults (18 years and over) with Multiple 
Sclerosis (MS) related walking disability. In multiple sclerosis, inflammation destroys the protective 
sheath around the nerves leading to muscle weakness, muscle stiffness and difficulty walking.  </p>
<p>Fampridine Accord contains the active substance fampridine which belongs to a group of medicines 
called potassium channel blockers. They work by stopping potassium leaving the nerve cells which 
have been damaged by MS. This medicine is thought to work by letting signals pass down the nerve 
more normally, which allows you to walk better. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take  Fampridine Accord  </p>
<p>if you are allergic to fampridine or any of the other ingredients of this medicine (listed in 
section 6) </p>
<p>if you have a seizure or have ever had a seizure (also referred to as a fit or convulsion) </p>
<p>if your doctor or nurse has told you that you have moderate or severe kidney problems </p>
<p>if you are taking a medicine called cimetidine </p>
<p>if you are taking any other medicine containing fampridine. This may increase your risk of 
serious side effects </p>
<p>Tell your doctor and do not take Fampridine Accord if any of these apply to you. </p>
<p>Warnings and precautions </p>
<p>Talk to your doctor or pharmacist before taking Fampridine Accord: </p>
<p>if you feel aware of your heartbeat (palpitations) </p>
<p>if you are prone to infections </p>
<p>you should use a walking aid, such as a cane, as needed </p>
<p>because this medicine may make you feel dizzy or unsteady this may result in an increased risk 
of falls </p>
<p>if you have any factors or are taking any medicine which affects your risk of fits (seizure). </p>
<p>if you have been told by a doctor that you have mild problems with your kidneys. </p>
<p>Tell your doctor before you take Fampridine Accord if any of these apply to you. </p>
<p>Children and in adolescents </p>
<p>Do not give Fampridine Accord to children or adolescents under the age of 18 years. </p>
<p>Elderly 
Before starting treatment and during treatment your doctor may check that your kidneys are working 
properly. </p>
<p>Other medicines and Fampridine Accord </p>
<p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. </p>
<p>Do not take Fampridine Accord if you are taking any other medicine containing fampridine. </p>
<p>Other medicines that affect the kidneys </p>
<p>Your doctor will be especially careful if fampridine is given at the same time as any medicine which 
may affect how your kidneys eliminate medicines for example carvedilol, propranolol  and metformin. </p>
<p>Fampridine Accord with food and drink </p>
<p>Fampridine Accord should be taken without food, on an empty stomach. </p>
<p>Pregnancy and breast-feeding </p>
<p>If you are pregnant, or are planning to become pregnant, tell your doctor before you take 
Fampridine Accord.<br />
Fampridine Accord is not recommended during pregnancy. </p>
<p>Your doctor will consider the benefit of you being treated with Fampridine Accord 
against the risk to your baby. </p>
<p>You should not breast-feed whilst taking this medicine. </p>
<p>Driving and using machines </p>
<p>Fampridine Accord may have an effect on people s ability to drive or use machines, it can cause 
dizziness. Make sure you re not affected before you start driving or use machinery. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure. Fampridine Accord is only available by prescription and under the supervision of 
doctors experienced in MS. </p>
<p>Your doctor will give you an initial prescription for 2 to 4 weeks. After 2 to 4 weeks the treatment 
will be reassessed. </p>
<p>The recommended dose is </p>
<p>One tablet in the morning and one tablet in the evening (12 hours apart). Do not take more than two 
tablets in a day. You must leave 12 hours between each tablet. Do not take the tablets more often 
than every 12 hours. </p>
<p>Swallow each tablet whole, with a drink of water. Do not divide, crush, dissolve, suck or chew the 
tablet. This may increase your risk of side effects. </p>
<p>If you take more Fampridine Accord than you should </p>
<p>Contact your doctor immediately if you take too many tablets. 
Take the Fampridine Accord box with you if you go to see the doctor. 
In overdose you may notice sweating, minor shaking (tremor), dizziness, confusion, memory loss 
(amnesia) and fits (seizure). You may also notice other effects not listed here. </p>
<p>If you forget to take  Fampridine Accord 
If you forget to take a tablet, do not take two tablets at once to make up for a missed dose. You must 
always leave 12 hours between each tablet. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>If you have a seizure, stop taking Fampridine Accord and tell your doctor immediately. </p>
<p>If you experience one or more of the following allergic (hypersensitivity) symptoms: swollen face, 
mouth, lips, throat or tongue, reddening or itching of the skin, chest tightness and breathing problems 
stop taking Fampridine Accord and see your doctor immediately. </p>
<p>Side effects are listed below by frequency: </p>
<p>Very Common side effects </p>
<p>May affect more than 1 in 10 people: 
* Urinary tract infection </p>
<p>Common side effects </p>
<p>May affect up to 1 in 10 people: 
* Feeling unsteady 
* Dizziness 
* Spinning sensation (vertigo)<br />
* Headache 
* Feeling weak and tired 
* Difficulty sleeping 
* Anxiety 
* Minor shaking (tremor) 
* Numbness or tingling of skin 
* Sore throat 
* Common cold (nasopharyngitis) 
* Flu (influenza) 
* Difficulty breathing (shortness of breath) 
* Feeling sick (nausea) 
* Being sick (vomiting) 
* Constipation 
* Upset stomach 
* Back pain 
* Heartbeat that you can feel (palpitations) </p>
<p>Uncommon side effects </p>
<p>May affect up to 1 in 100 people 
* Fits (seizure) 
* Allergic reaction (hypersensitivity) 
* New onset or worsening of nerve pain in the face (trigeminal neuralgia) 
* Fast heart rate (tachycardia) </p>
<p>Reporting of side effects </p>
<p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety 
of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry 
date refers to the last day of that month. </p>
<p>This medicinal product does not require any special storage conditions.  </p>
<p>Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help to protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Fampridine Accord contains  </p>
<ul>
<li>The active substance is fampridine.  </li>
<li>Each prolonged-release tablet contains 10 mg of fampridine  </li>
<li>
<p>The other ingredients are:</p>
</li>
<li>
<p>Tablet core: Hypromellose (E464), silica, colloidal anhydrous (E551), cellulose 
microcrystalline (E460), magnesium stearate (E572);  </p>
</li>
<li>Film coating: hypromellose (E464), titanium dioxide (E171), macrogol (E1521) </li>
</ul>
<p>What Fampridine Accord looks like and contents of the pack </p>
<p>White to off white, oval shaped, biconvex, bevel-edged, film coated tablets, approximately 
13.1 x 8.1 mm in dimensions, debossed with  FH6  on one side and plain on other side. </p>
<p>Fampridine Accord 10 mg prolonged-release tablets are packed in perforated unit-dose blister packs 
containing 28 x1 or 56 x 1 tablets </p>
<p>Not all pack sizes may be marketed.  </p>
<p>Marketing Authorisation Holder </p>
<p>Accord Healthcare S.L.U. 
World Trade Center, Moll de Barcelona s/n,<br />
Edifici Est, 6a Planta,<br />
Barcelona, 08Spain </p>
<p>Manufacturer 
Accord Healthcare Polska Sp.z.o.o. 
Ul. Lutomierska 50, 
95-200, Pabianice, Poland </p>
<p>Pharmadox Healthcare Ltd. 
KW20A Kordin Industrial Park, Paola PLA3000, Malta </p>
<p>Laboratori Fundaci  DAU 
C/ C, 12-14 Pol. Ind. Zona Franca, 08040 Barcelona, Spain </p>
<p>This leaflet was last revised in  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: CompositionUvEpi
Title: "Composition for fampridine Package Leaflet"
Description:  "Composition for fampridine Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp39498dc221c8f1bc0b8c1dfe4bd3662c)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - fampridine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen: </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal du vide, før du begynder at tage Fampridine Accord </li>
<li>Sådan skal du tage Fampridine Accord </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What fampridine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What fampridine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fampridine Accord indeholder det aktive stof fampridin, som tilhører en gruppe lægemidler, der 
kaldes kaliumkanal-blokkere. Deres funktion er at forhindre kalium i at forlade de nerveceller, som er 
blevet beskadiget af MS. Det antages, at lægemidlet virker ved at lade signaler passere mere normalt 
ned gennem nerven, hvilket giver dig mulighed for at gå bedre. </p>
<p>Fampridine Accord er et lægemiddel, der anvendes til at forbedre gangfunktionen hos voksne (18 år 
og ældre) med gangproblemer grundet multipel sklerose (MS). Ved multipel sklerose ødelægger en 
betændelsestilstand den beskyttende hinde omkring nerverne, hvilket medfører muskelsvaghed, 
muskelstivhed og gangproblemer. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Fampridine Accord </p>
<p>− 
hvis du er allergisk over for fampridin eller et af de øvrige indholdsstoffer i Fampridine Accord 
(angivet i punkt 6) 
− 
hvis du har kramper eller nogensinde har haft et krampeanfald (kaldes også anfald eller 
kramper) 
− 
hvis din læge eller sygeplejersken har fortalt dig, at du har moderate eller svære nyreproblemer 
− 
hvis du tager et lægemiddel, som hedder cimetidin 
− 
hvis du tager andre lægemidler indeholdende fampridin. Det kan øge risikoen for alvorlige 
bivirkninger </p>
<p>Tal med din læge og lad være med at tage Fampridine Accord, hvis noget af dette gælder for dig. </p>
<p>Advarsler og forsigtighedsregler </p>
<p>Kontakt lægen eller apoteket, før du tager Fampridine Accord 
− 
hvis du kan mærke dine hjerteslag (har hjertebanken) 
− 
hvis du er tilbøjelig til at få infektioner 
− 
hvis der er faktorer, eller du får medicin, der påvirker din risiko for at få krampeanfald. 
− 
hvis din læge har fortalt dig, at du har lette nyreproblemer 
− 
hvis du tidligere har haft allergiske reaktioner </p>
<p>Du skal bruge et hjælpemiddel til at gå såsom en stok efter behov. Da dette lægemiddel kan gøre dig 
svimmel eller usikker på benene, kan det medføre en øget risiko for fald. </p>
<p>Tal med din læge inden du tager Fampridine Accord, hvis noget af dette gælder for dig. </p>
<p>Børn og unge </p>
<p>Giv ikke lægemidlet til børn eller unge under 18 år. </p>
<p>Ældre </p>
<p>Inden du starter behandlingen og under behandlingen, vil din læge muligvis undersøge, om dine nyrer 
fungerer, som de skal. </p>
<p>Brug af anden medicin sammen med Fampridine Accord </p>
<p>Fortæl altid lægen eller apotekspersonalet, hvis du tager anden medicin, for nylig har taget anden 
medicin eller planlægger at tage anden medicin.. </p>
<p>Tag ikke Fampridine Accord, såfremt du tager anden medicin som indeholder fampridin. </p>
<p>Anden medicin, som påvirker nyrerne </p>
<p>Din læge vil være særlig forsigtig, hvis fampridin gives på samme tid som andre lægemidler, der kan 
påvirke hvordan dine nyrer udskiller medicin, eksempelvis carvedilol, propranolol og metformin. </p>
<p>Graviditet og amning </p>
<p>Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge eller apotekspersonalet til råds, før du tager dette lægemiddel. </p>
<p>Fampridine Accord anbefales ikke under graviditet. </p>
<p>Lægen vil overveje fordelene ved at behandle dig med Fampridine Accord i forhold til risikoen for dit 
barn. </p>
<p>Du bør ikke amme, mens du tager denne medicin. </p>
<p>Trafik- og arbejdssikkerhed </p>
<p>Fampridine Accord kan påvirke evnen til at køre eller betjene maskiner, det kan forårsage 
svimmelhed. Sørg for ikke at være påvirket, før du begynder at køre eller betjene maskiner. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens anvisning. Er du i tvivl, så spørg lægen eller 
apotekspersonalet. Fampridine Accord er receptpligtigt og behandlingen skal forestås af læger med 
erfaring i behandling af MS. </p>
<p>Din læge vil starte med at udskrive medicin til 2 til 4 uger. Efter 2 til 4 uger vil behandlingen blive 
revurderet. </p>
<p>Den anbefalede dosis er </p>
<p>Én tablet om morgenen og én tablet om aftenen (med 12 timers mellemrum). Tag ikke mere end to 
tabletter om dagen. Lad der gå 12 timer mellem hver tablet. Tag ikke tabletterne oftere end hver 12. time. </p>
<p>Fampridine Accord er til oral anvendelse. </p>
<p>Tabletterne skal synkes hele med lidt vand. Tabletterne må hverken deles, knuses, opløses, suttes 
eller tygges. Det kan øge bivirkningerne. </p>
<p>Dette lægemiddel bør indtages uden mad, på tom mave. </p>
<p>Hvis du har taget for meget Fampridine Accord 
Kontakt straks lægen, hvis du har taget for mange tabletter. 
Tag Fampridine Accord-æsken med til lægen. 
Ved en overdosis kan du opleve sveden, små ufrivillige, rystende, rytmiske bevægelser (tremor), 
svimmelhed, forvirring, hukommelsessvigt og krampeanfald. Du kan også opleve andre bivirkninger, 
som ikke er nævnt her. </p>
<p>Hvis du har glemt at tage Fampridine Accord 
Hvis du har glemt at tage en tablet, må du ikke tage en dobbeltdosis som erstatning for den glemte 
dosis. Du skal altid lade 12 timer gå mellem hver tablet. </p>
<p>Spørg lægen, apotekspersonalet eller sygeplejersken, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Hvis du får et krampeanfald, skal du omgående stoppe med at tage Fampridine Accord og 
informere din læge herom. </p>
<p>Hvis du oplever et eller flere af følgende symptomer på allergi (overfølsomhed): hævelse af ansigt, 
mund, læber, hals eller tunge, hudrødme eller hudkløe, trykken for brystet og problemer med 
vejrtrækningen, skal du stoppe med at tage Fampridine Accord og kontakte en læge med det 
samme. </p>
<p>Bivirkninger anføres i det følgende efter hyppighed: </p>
<p>Meget almindelige bivirkninger </p>
<p>Kan forekomme hos flere end 1 ud af 10 brugere: </p>
<ul>
<li>Urinvejsinfektion </li>
</ul>
<p>Almindelige bivirkninger </p>
<p>Kan forekomme hos op til 1 ud af 10 brugere: </p>
<ul>
<li>
<p>Usikkerhed på benene </p>
</li>
<li>
<p>Svimmelhed </p>
</li>
<li>
<p>Rundtossethed (vertigo) </p>
</li>
<li>
<p>Hovedpine </p>
</li>
<li>
<p>Følelse af svaghed og træthed </p>
</li>
<li>
<p>Søvnproblemer </p>
</li>
<li>
<p>Angst </p>
</li>
<li>
<p>Små ufrivillige, rystende, rytmiske bevægelser (tremor) </p>
</li>
<li>
<p>Følelsesløshed eller prikken i huden </p>
</li>
<li>
<p>Ondt i halsen </p>
</li>
<li>
<p>Forkølelse (nasofaryngitis) </p>
</li>
<li>
<p>Influenza </p>
</li>
<li>
<p>Virusinfektion </p>
</li>
<li>
<p>Åndedrætsbesvær (kortåndethed) </p>
</li>
<li>
<p>Kvalme </p>
</li>
<li>
<p>Opkast </p>
</li>
<li>
<p>Forstoppelse </p>
</li>
<li>
<p>Diarré </p>
</li>
<li>
<p>Rygsmerter </p>
</li>
<li>
<p>Hjertebanken, du kan mærke dine hjerteslag (palpitationer) </p>
</li>
</ul>
<p>Ikke almindelige bivirkninger </p>
<p>Kan forekomme hos op til 1 ud af 100 brugere </p>
<ul>
<li>
<p>Krampeanfald </p>
</li>
<li>
<p>Allergisk reaktion (overfølsomhed) </p>
</li>
<li>
<p>Svær allergi (anafylaktisk reaktion) </p>
</li>
<li>
<p>Hævelse af ansigt, læber, mund eller tunge (angioødem) </p>
</li>
<li>
<p>Fremkomst af nye eller forværring af nervesmerter i ansigtet (trigeminusneuralgi) </p>
</li>
<li>
<p>Hurtige hjerteslag (takykardi) </p>
</li>
<li>
<p>Svimmelhed eller bevidsthedstab (hypotension) </p>
</li>
<li>
<p>Udslæt/kløende udslæt (urticaria) </p>
</li>
<li>
<p>Brystgener </p>
</li>
</ul>
<p>Indberetning af bivirkninger </p>
<p>Hvis du oplever bivirkninger, bør du tale med din læge, eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store fampridine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store fampridine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar dette lægemiddel utilgængeligt for børn. </p>
<p>Brug ikke dette lægemiddel efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er 
den sidste dag i den nævnte måned. </p>
<p>Der er ingen særlige krav vedrørende opbevaringen af dette lægemiddel. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fampridine Accord indeholder: </p>
<p>− 
Det aktive stof er fampridin. 
− 
Hver depottablet indeholder 10 mg fampridin 
− 
Øvrige indholdsstoffer: 
− 
Tabletkerne: hypromellose (E464), kolloid vandfri silica (E551), mikrokrystallinsk 
cellulose (E460), magnesiumstearat (E572) 
− 
Filmovertræk: hypromellose (E464), titandioxid (E171), macrogol (E1521) </p>
<p>Udseende og pakningsstørrelser </p>
<p>Hvide til offwhite, ovale, bikonvekse filmovertrukne tabletter med facetslebne kanter, ca. 
13,1 x 8,1 mm, præget med ‘FH6’ på den ene side og jævne på den anden side. </p>
<p>Fampridine Accord 10 mg depottabletter er pakket i perforerede enhedsdosisblisterpakninger 
indeholdende 28 x 1 eller 56 x 1 tabletter. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>Indehaver af markedsføringstilladelsen </p>
<p>Accord Healthcare S.L.U. 
World Trade Center, Moll de Barcelona s/n,<br />
Edifici Est, 6a Planta,<br />
Barcelona, 08Spanien </p>
<p>Fremstiller </p>
<p>Accord Healthcare Polska Sp.z.o.o. 
Ul. Lutomierska 50, 
95-200, Pabianice, Polen </p>
<p>Pharmadox Healthcare Ltd. 
KW20A Kordin Industrial Park, Paola PLA3000, Malta </p>
<p>Laboratori Fundació DAU 
C/ C, 12-14 Pol. Ind. Zona Franca, 08040 Barcelona, Spanien </p>
<p>Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ} </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu/. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for fampridine Package Leaflet for language en"
Description: "ePI document Bundle for fampridine Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-63de51a4556de5e7a2f7d84ffc03fbf9"
* entry[0].resource = composition-en-63de51a4556de5e7a2f7d84ffc03fbf9

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp63de51a4556de5e7a2f7d84ffc03fbf9"
* entry[=].resource = mp63de51a4556de5e7a2f7d84ffc03fbf9
                            
                    
Instance: bundlepackageleaflet-da-63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for fampridine Package Leaflet for language da"
Description: "ePI document Bundle for fampridine Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-63de51a4556de5e7a2f7d84ffc03fbf9"
* entry[0].resource = composition-da-63de51a4556de5e7a2f7d84ffc03fbf9

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp63de51a4556de5e7a2f7d84ffc03fbf9"
* entry[=].resource = mp63de51a4556de5e7a2f7d84ffc03fbf9
                            
                    



Instance: mp63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Fampridine Accord 10 mg prolonged-release tablets"
Description: "Fampridine Accord 10 mg prolonged-release tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/20/1477/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Fampridine Accord 10 mg prolonged-release tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 63de51a4556de5e7a2f7d84ffc03fbf9ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "fampridine"

* status = #current
* mode = #working

* title = "List of all ePIs associated with fampridine"

* subject = Reference(mp39498dc221c8f1bc0b8c1dfe4bd3662c)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#fampridine "fampridine"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-63de51a4556de5e7a2f7d84ffc03fbf9) // fampridine en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-63de51a4556de5e7a2f7d84ffc03fbf9) // fampridine da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-63de51a4556de5e7a2f7d84ffc03fbf9
InstanceOf: List

* insert 63de51a4556de5e7a2f7d84ffc03fbf9ListRuleset
    